文献速递中毒与环境急症重症综合管理与镇静镇痛

双重血浆分子吸附治疗重症黄蜂蜇伤的效果与安全性:多中心历史队列研究

[Effect and safety of double plasma molecular absorption in treatment of patients with severe wasp stings injury: a multicenter historical cohort study].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2023-01-01
一句话结论CVVH+DPMA+HP方案可显著降低重症黄蜂蜇伤患者的APACHE II评分,疗效优于CVVH+HP和CVVH+PE方案且安全。

该多中心历史队列研究纳入5家医院ICU收治的重症黄蜂蜇伤伴多器官损伤患者,干预组(2020年7月至2022年10月连续筛选)接受CVVH+DPMA+HP,采用倾向性评分1:1匹配2016年1月至2020年6月的历史对照(CVVH+HP组和CVVH+PE组各56例)。主要终点为治疗启动后第3天和第7天APACHE II评分。结果显示各组APACHE II评分均显著下降,干预组下降更快;DPMA治疗(HR=1.04,95%CI 1.02-1.08,P=0.00)、体温下降水平(HR=1.02,95%CI 1.00-1.03,P=0.02)、血清肌酸激酶下降水平(HR=0.98,95%CI 0.96-1.00,P=0.05)和肌红蛋白下降水平(HR=2.88,95%CI 1.24-6.69,P=0.01)是APACHE II评分降至目标值(15分)的独立影响因素。各组出血并发症、滤器或灌流器血栓、血压下降、导管相关感染及过敏反应发生率无显著差异。结论认为CVVH+DPMA+HP方案能显著降低重症黄蜂蜇伤患者APACHE II评分,疗效优于CVVH+HP和CVVH+PE方案,且安全。

要点

  • 重症黄蜂蜇伤伴多器官损伤患者采用CVVH+DPMA+HP方案,APACHE II评分下降速度快于CVVH+HP和CVVH+PE方案。
  • DPMA治疗是APACHE II评分降至目标值15分的独立影响因素(HR=1.04,95%CI 1.02-1.08,P=0.00)。
  • 体温下降水平(HR=1.02,95%CI 1.00-1.03,P=0.02)、肌酸激酶下降水平(HR=0.98,95%CI 0.96-1.00,P=0.05)和肌红蛋白下降水平(HR=2.88,95%CI 1.24-6.69,P=0.01)是APACHE II评分降至目标值的独立影响因素。
  • 各组出血并发症、滤器或灌流器血栓、血压下降、导管相关感染及过敏反应发生率无显著差异。
  • 该研究为多中心历史队列研究,采用倾向性评分1:1匹配,干预组与两个历史对照组各56例。

适用人群与场景

  • 5家医院ICU收治的重症黄蜂蜇伤伴多器官损伤患者。
  • 干预组为2020年7月至2022年10月连续筛选并纳入的患者。
  • 历史对照组为2016年1月至2020年6月住院的同类患者,按实际血液净化方案分为CVVH+HP组和CVVH+PE组,并与干预组1:1匹配。

诊断标准与关键阈值

  • 主要终点目标值:APACHE II评分降至15分。

处置流程与药物剂量

  • 干预组:CVVH+DPMA+HP。
  • 历史对照1组:CVVH+HP。
  • 历史对照2组:CVVH+PE。

研究设计与关键结果

  • 研究类型:多中心历史队列研究,采用优势检验和倾向性评分匹配;5家医院ICU参与;干预组与两个历史对照组各匹配56例。
  • 基线:匹配后各组年龄、性别、合并症、生化检测指标及危重程度评分无显著差异。
  • 主要终点:治疗后各组APACHE II评分均显著下降,干预组下降更快。
  • 多因素Cox回归:DPMA治疗(HR=1.04,95%CI 1.02-1.08,P=0.00)、体温下降水平(HR=1.02,95%CI 1.00-1.03,P=0.02)、血清肌酸激酶下降水平(HR=0.98,95%CI 0.96-1.00,P=0.05)和肌红蛋白下降水平(HR=2.88,95%CI 1.24-6.69,P=0.01)是APACHE II评分降至目标值(15分)的独立影响因素。
  • 安全性:各组出血并发症、滤器或灌流器血栓、血压下降、导管相关感染及过敏反应发生率无显著差异。

证据类型、等级与局限

  • 证据类型:多中心历史队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 对于重症黄蜂蜇伤伴多器官损伤的ICU患者,作者认为CVVH+DPMA+HP方案可显著降低APACHE II评分,疗效优于CVVH+HP和CVVH+PE方案,且安全。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To compare the effect and safety of continuous veno-venous hemofiltration (CVVH)+double plasma molecular absorption (DPMA)+hemoperfusion (HP), CVVH+HP, and CVVH+plasma exchange (PE) in treatment of patient with severe wasp stings injury.

METHODS: Multicenter, historical cohort study and superiority test were used. From July 2020 to October 2022, patients with wasp sting injury and multiple organ damage admitted to the intensive care units (ICU) of five hospitals were consecutively screened and recruited into the CVVH+DPMA+HP group (intervention group). Propensity score matching was used to establish historical cohorts. Patients with severe wasp sting injury who hospitalized from January 2016 to June 2020 in each ICU were collected and matched 1:1 with the intervention group, and divided into CVVH+HP group and CVVH+PE group according to their actual hemopurification protocols (historical control groups). The primary outcome was the acute physiology and chronic health evaluation II (APACHE II) score on days 3 and 7 after initiation of treatment. Secondary outcomes included complications, length of ICU and hospital stays, and all-cause mortality. Multivariate Cox proportional risk regression was used to analyze the prognosis of patients.

RESULTS: After propensity score matching, 56 patients in intervention group and each of the two historical control groups were matched successfully. There were no significant differences in age, gender, comorbidities, biochemical test indices and critical illness scores among the groups. After treatment, APACHE II score markedly declined in all groups, and the decrease was faster in the intervention group; treatment with DPMA [hazard ratio (HR) = 1.04, 95% confidence interval (95%CI) was 1.02-1.08, P = 0.00], the decreased levels of body temperature (HR = 1.02, 95%CI was 1.00-1.03, P = 0.02), serum creatine kinase (CK; HR = 0.98, 95%CI was 0.96-1.00, P = 0.05) and myoglobin (MYO; HR = 2.88, 95%CI was 1.24-6.69, P = 0.01) were independent risk factors for APACHE II score decline to the target value (15 scores). There were no significant differences in the incidence of bleeding complications, filter or perfusion thrombosis, blood pressure reduction, catheter-related infection and anaphylaxis among the groups.

CONCLUSIONS: CVVH+DPMA+HP regimen can significantly reduce the APACHE II score of patients with severe wasp sting injury, and the efficacy is superior to CVVH+HP and CVVH+PE regimens, with safety.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Wei T, Liao H, Xiao J, et al. [Effect and safety of double plasma molecular absorption in treatment of patients with severe wasp stings injury: a multicenter historical cohort study]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2023. PMID: 36916338. doi:10.3760/cma.j.cn121430-20221116-01001

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。